Loading clinical trials...
Loading clinical trials...
A Phase 2B Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel-design Study of the Efficacy and Safety of VX-150 for Acute Pain Following Bunionectomy
Conditions
Interventions
VX-150
Placebo
Locations
6
United States
Arizona Research Center
Phoenix, Arizona, United States
Anaheim Clinical Trials
Anaheim, California, United States
Lotus Clinical Research
Pasadena, California, United States
Chesapeake Research Group
Pasadena, Maryland, United States
Endeavor Clinical Trials
San Antonio, Texas, United States
JBR Clinical Research
Salt Lake City, Utah, United States
Start Date
December 12, 2018
Primary Completion Date
January 17, 2019
Completion Date
January 25, 2019
Last Updated
February 9, 2022
NCT07422272
NCT07310953
NCT06184126
NCT06471075
NCT06569953
NCT06853041
Lead Sponsor
Vertex Pharmaceuticals Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions